TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Jacomm /Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 12,974 | 12,673 | 11,806 |
Financial expenses | 82 | 39 | 40 |
Earnings before taxes | -223 | 836 | 360 |
EBITDA | -159 | 881 | 411 |
Total assets | 5,459 | 5,036 | 4,528 |
Current assets | 5,411 | 5,026 | 4,507 |
Current liabilities | 3,477 | 1,985 | 2,039 |
Equity capital | 1,023 | 2,072 | 1,454 |
- share capital | 51 | 47 | 49 |
Employees (average) | 3 | 3 | 3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 18.7% | 41.1% | 32.1% |
Turnover per employee | 4,325 | 4,224 | 3,935 |
Profit as a percentage of turnover | -1.7% | 6.6% | 3.0% |
Return on assets (ROA) | -2.6% | 17.4% | 8.8% |
Current ratio | 155.6% | 253.2% | 221.0% |
Return on equity (ROE) | -21.8% | 40.3% | 24.8% |
Change turnover | -599 | 1,222 | 430 |
Change turnover % | -4% | 11% | 4% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.